Submission Details
| 510(k) Number | K140957 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 14, 2014 |
| Decision Date | January 15, 2015 |
| Days to Decision | 276 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
K140957 is an FDA 510(k) clearance for the GENASIS HIPATH IHC FAMILY, a Microscope, Automated, Image Analysis, Immunohistochemistry,operator Intervention,nuclear Intensity & Percent Positivity (Class II — Special Controls, product code NQN), submitted by Applied Spectral Imaging , Ltd. (Caesarea, IL). The FDA issued a Cleared decision on January 15, 2015, 276 days after receiving the submission on April 14, 2014. This device falls under the Pathology review panel. Regulated under 21 CFR 864.1860.
| 510(k) Number | K140957 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 14, 2014 |
| Decision Date | January 15, 2015 |
| Days to Decision | 276 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
| Product Code | NQN — Microscope, Automated, Image Analysis, Immunohistochemistry,operator Intervention,nuclear Intensity & Percent Positivity |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.1860 |
| Definition | Automated Microscopic Immunohistochemistry Image- Analysis System To Measure Nuclear Intensity And Percent Positivity With Operator Intervention. |